Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20040054414 A1
Publication typeApplication
Application numberUS 10/245,955
Publication dateMar 18, 2004
Filing dateSep 18, 2002
Priority dateSep 18, 2002
Also published asCA2499111A1, CA2505169A1, EP1562652A1, US7713303, US20040228901, US20050197707, WO2004026189A2, WO2004026189A3, WO2004045667A1
Publication number10245955, 245955, US 2004/0054414 A1, US 2004/054414 A1, US 20040054414 A1, US 20040054414A1, US 2004054414 A1, US 2004054414A1, US-A1-20040054414, US-A1-2004054414, US2004/0054414A1, US2004/054414A1, US20040054414 A1, US20040054414A1, US2004054414 A1, US2004054414A1
InventorsHai Trieu, Michael Sherman
Original AssigneeTrieu Hai H., Sherman Michael C.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Collagen-based materials and methods for augmenting intervertebral discs
US 20040054414 A1
Abstract
A method of augmenting an intervertebral disc by injecting particles of collagen-based material into the disc. The particles may be dehydrated before implantation, and rehydrated after implantation, or they may be implanted in a “wet” state—such as a slurry or gel. Radiocontrast materials may be included to enhance imaging of the injected material. Other additives may include analgesics, antibiotics, proteoglycans, growth factors, and/or other cells effective to promote healing and/or proper disc function.
Images(7)
Previous page
Next page
Claims(34)
What is claimed is:
1. A method of augmenting an intervertebral disc, said method comprising surgically adding to an intervertebral disc a composition comprising particulate collagen-based material.
2. The method of claim 1 wherein said surgically adding step comprises injecting particulate collagen-based material into an intervertebral disc.
3. The method of claim 1 wherein said collagen-based material comprises particles ranging from 0.05 mm to 5 mm in size.
4. The method of claim 1 wherein said collagen-based material comprises particles ranging from 0.05 mm to 3 mm in size.
5. The method of claim 1 wherein said collagen-based material comprises particles ranging from 0.05 mm to 1 mm in size.
6. The method of claim 1 wherein said collagen-based material comprises particles ranging from 0.25 mm to 1 mm in size.
7. The method of claim 1 wherein said collagen-based material is injected in a dehydrated state.
8. The method of claim 1 wherein said collagen-based material is injected in a non-dehydrated state.
9. The method of claim 8 wherein said collagen-based material is injected as a gel.
10. The method of claim 8 wherein said collagen-based material is injected as a solution or suspension.
11. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes a cross-linking agent to promote crosslinking of collagen molecules.
12. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes a radiocontrast media.
13. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes an analgesic.
14. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes an antibiotic.
15. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes proteoglycans.
16. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes growth factors.
17. The method of claim 1 wherein said collagen-based material is provided as a formulation that additionally includes one or more other types of cells effective to promote healing, repair, regeneration and/or restoration of the disc, and/or to facilitate proper disc function.
18. An intervertebral disc augmented with particulate collagen-based material.
19. The augmented disc of claim 18 wherein said collagen-based material comprises collagen-based material that has been injected into the disc.
20. The augmented disc of claim 18 wherein said collagen-based material comprises particles ranging from 0.05 mm to 5 mm in size.
21. The augmented disc of claim 18 wherein said collagen-based material comprises particles ranging from 0.05 mm to 3 mm in size.
22. The augmented disc of claim 18 wherein said collagen-based material comprises particles ranging from 0.05 mm to 1 mm in size.
23. The augmented disc of claim 18 wherein said collagen-based material comprises particles ranging from 0.25 mm to 1 mm in size.
24. The augmented disc of claim 18 wherein said collagen-based material comprises collagen-based materials that have been reconstituted in the disc from dehydrated collagen-based materials.
25. The augmented disc of claim 18 wherein said collagen-based material comprises collagen-based materials that were injected into the disc in a non-dehydrated state.
26. The augmented disc of claim 18 wherein said collagen-based material comprises collagen-based materials that were injected into the disc as a gel.
27. The augmented disc of claim 18 wherein said collagen-based material comprises collagen-based materials that were injected into the disc as a solution or suspension.
28. The augmented disc of claim 18 wherein said collagen-based material additionally includes a cross-linking agent to promote crosslinking of collagen molecules.
29. The augmented disc of claim 18 wherein said collagen-based material additionally includes a radiocontrast media.
30. The augmented disc of claim 18 wherein said collagen-based material additionally includes an analgesic.
31. The augmented disc of claim 18 wherein said collagen-based material additionally includes an antibiotic.
32. The augmented disc of claim 18 wherein said collagen-based material additionally includes proteoglycans.
33. The augmented disc of claim 18 wherein said collagen-based material additionally includes growth factors.
34. The augmented disc of claim 18 wherein said collagen-based material additionally includes one or more other types of cells effective to promote healing, repair, regeneration and/or restoration of the disc, and/or to facilitate proper disc function.
Description
    FIELD OF THE INVENTION
  • [0001]
    The present invention relates generally to materials and methods for augmenting intervertebral discs, and more particularly to materials and methods for augmenting intervertebral discs with collagen-based materials.
  • BACKGROUND OF THE INVENTION
  • [0002]
    A healthy intervertebral disc facilitates motion between pairs of vertebrae while absorbing and distributing shocks. The disc is composed of two parts: a soft central core (the nucleus pulposus) that bears the majority of the load, and a tough outer ring (the annulus fibrosis) that holds and stabilizes the core material.
  • [0003]
    As the natural aging process progresses, the disc may dehydrate and degenerate, adversely affecting its ability to adequately cushion and support the vertebral bodies. This natural desiccation, which in its more advanced state is often referred to as “black disc” because of the disc's dehydrated appearance on Magnetic Resonance Imaging [MRI], can cause discomfort to the patient as the vertebrae to come closer together compressing the spinal nerves and causing pain.
  • [0004]
    Techniques for addressing degenerative disc disease have heretofore relied primarily on disc replacement methods. In cases in which a dehydrated and/or degenerating disc was augmented before disc replacement was required, the augmentation materials have primarily been synthetic devices that expand, are inflated, or deploy expanding elements when implanted into the disc.
  • [0005]
    A need therefore exists for materials and methods effective for augmenting intervertebral discs with natural materials. The present invention addresses that need.
  • SUMMARY OF THE INVENTION
  • [0006]
    Briefly describing one aspect of the present invention, there is provided a method of augmenting an intervertebral disc by injecting particles of collagen-based material into the disc. The particles may be implanted in a dehydrated form, and rehydrated after implantation, or they may be implanted in a hydrated form, such as a slurry or gel. Cross-linking agents such as glutaraldehyde may be included in the injected material to promote collagen crosslinking. In addition, radio-contrast materials may be included to enhance imaging of the injected material. Similarly, performance-enhancing additives such as analgesics and/or antibiotics may be included to provide additional therapeutic benefits.
  • [0007]
    Objects and advantages of the claimed invention will be apparent from the following description.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0008]
    FIGS. 1A-1D show a procedure for injecting a collagen-based material into an intervertebral disc, according to one preferred embodiment of the present invention.
  • [0009]
    FIGS. 2A-2F show a procedure for injecting a collagen-based material into an intervertebral disc, according to another preferred embodiment of the present invention.
  • DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0010]
    For the purposes of promoting an understanding of the principles of the invention, reference will now be made to certain preferred embodiments and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended, such alterations and further modifications in the preferred embodiments being contemplated as would normally occur to one skilled in the art to which the invention relates.
  • [0011]
    As indicated above, one aspect of the present invention relates to materials and methods for using collagen-based material to augment an intervertebral disc. In the most preferred embodiments the collagen-based material is injected into a disc nucleus that is contained in a substantially sound annulus. In other embodiments the collagen-based material is injected into a disc nucleus that is contained in a damaged or defective annulus.
  • [0012]
    The collagen-based material is preferably derived from natural, collagen-rich tissue, such as intervertebral disc, fascia, ligament, tendon, demineralized bone matrix, etc. The material may be autogenic, allogenic, or xenogenic, or it may be of human-recombinant origin. In alternative embodiments the collagen-based material may be a synthetic, collagen-based material. Examples of preferred collagen-rich tissues include disc annulus, fascia lata, planar fascia, anterior or posterior cruciate ligaments, patella tendon, hamstring tendons, quadriceps tendons, Achilles tendons, skins, and other connective tissues.
  • [0013]
    The collagen-based material may be provided in any form appropriate for introduction into a disc space. For example, the material may be a solid, porous, woven, or non-woven material. The material may be provided as particles or small pieces, or as a fibrous material.
  • [0014]
    In some embodiments the material is provided in a dehydrated state, and is “rehydrated” after implantation in the disc. In other embodiments the material is implanted “wet.” When the material is “wet,” it may be that way because it has never been dehydrated, or it may have been dehydrated and reconstituted. When reconstituted, the material may be reconstituted with saline or another aqueous medium, or it may be reconstituted with a non-aqueous medium such as ethylene glycol or another alcohol. Moreover, when provided in a “wet” state, the material may be provided as a gel, solution, suspension, dispersion, emulsion, paste, etc.
  • [0015]
    In the most preferred embodiments the material is a particulate and/or fibrous material suitable for injection through a hypodermic needle into a disc.
  • [0016]
    In the most preferred embodiments the collagen material is provided as particles ranging between 0.05 mm and 5 mm in size. When materials such as fascia lata or disc annulus particles are used the particles preferably range in size from 1 mm to 5 mm. When materials such as demineralized bone matrix are used the particles preferably range in size from 0.5 mm to 3 mm. When small plugs of material are used the plugs preferably range in size from 0.5 mm to 5 mm. In some embodiments larger sized pieces, such as pieces up to 20 mm in size, may be used.
  • [0017]
    The materials may be processed or fabricated using more than one type of tissue. For example, mixtures of fascia lata and demineralized bone matrix may be preferred in appropriate cases, as may mixtures of DBM and annulus fibrosis material.
  • [0018]
    Cross-linking agents may be added to the formulation to promote cross-linking of the collagen material. For example, glutaraldehyde or other protein cross-linking agents may be included in the formulation. The cross-linking agents may promote covalent or non-covalent crosslinks between collagen molecules. Similarly, agents to inhibit protein denaturization may also be included. Crosslinking agents that would be appropriate for use in the claimed invention are known to persons skilled in the art, and may be selected without undue experimentation.
  • [0019]
    When the material is to be used as a slurry or gel, additives to promote slurry or gel formation may also be included. These additives may promote protein folding, water binding, protein-protein interactions, and water immobilization.
  • [0020]
    In addition, a radiocontrast media, such as barium sulfate, or a radiocontrast dye, such as HYPAQUE®, may be included to aid the surgeon in tracking the movement and/or location of the injected material. Radiocontrast materials appropriate for use in discography are known to persons skilled in the art, and may be selected for use in the present invention without undue experimentation.
  • [0021]
    Finally, other additives to provide benefits to the injected collagen-based material may also be included. Such additives include anesthetics, to reduce pain caused by the procedure, and antibiotics, to minimize the potential for bacterial infection.
  • [0022]
    Proteoglycans may also be included to attract and/or bind water to keep the nucleus hydrated. Similarly, growth factors and/or other cells (e.g., intervertebral disc cells, stem cells, etc.) to promote healing, repair, regeneration and/or restoration of the disc, and/or to facilitate proper disc function, may also be included. Additives appropriate for use in the claimed invention are known to persons skilled in the art, and may be selected without undue experimentation.
  • [0023]
    In some embodiments the collagen material is dehydrated before injection into the disc space, where it is rehydrated by absorbing fluid from the disc space. In other embodiments the collagen material is provided as a gel, slurry, or other hydrated formulation before implantation.
  • [0024]
    The collagen-based material is “surgically added” to the disc space. That is, the material is added by the intervention of medical personnel, as distinguished from being “added” by the body's natural growth or regeneration processes. The surgical procedure preferably includes injection through a hypodermic needle, although other surgical methods of introducing the collagen-based material into the disc may be used. For example, the material may be introduced into a disc by extrusion through a dilated annular opening, infusion through a catheter, insertion through an opening created by trauma or surgical incision, or by other means of invasive or minimally invasive deposition of the materials into the disc space.
  • [0025]
    Referring now to the drawings, FIGS. 1A-1D show one method of injecting a collagen-based material into a disc. In FIG. 1A, dehydrated particulate fascia lata or annulus fibrosis material 11 is provided in a syringe 12 (in a sterile package). The material is rehydrated and/or dispersed in a suspension medium as shown in FIG. 1B, to provide a wet dispersion 13 of collagen-based material. A hypodermic needle 14 is attached to syringe 12, and the syringe is inserted into a nucleus pulposus 15 contained within a disc annulus 16 (FIG. 1C). The needle/syringe may be moved around within the disc space, sweeping from side to side and back and forth, to ensure uniform distribution of the collagen-based material 13 within the disc space, as shown in FIG. 1D. It is preferred, however, that the tip of the needle be maintained near the center of the disc to ensure deposition of the material within the nuclear disc space, and to minimize potential leakage.
  • [0026]
    Alternatively, small collagen plugs 21 may be inserted into the disc space as shown in FIGS. 2A-2F. The collagen plugs 21 may be compressed before or by insertion into a small diameter tube 22, and are provided in a delivery cannula 23 (FIGS. 2A-2C). The delivery cannula 23 is attached to a dilator 24.
  • [0027]
    The compressed plugs are inserted into a disc nucleus 25 having a substantially intact annulus 26 by penetrating the annulus with a guide needle 27 (FIG. 2D). Dilator 24, preferably with delivery cannula 23 already attached, is inserted through the annulus over guide needle 27 (FIG. 2E). The collagen plugs 21 are then ready for injection (or extrusion) into the disc space.
  • [0028]
    The collagen plugs are deposited into the disc space. As with the wet particulate/fibrous material, the cannula may be moved up and back, and/or side to side, to ensure even distribution of the plugs (FIG. 2F) a plunger 28 may be used to push the plugs from the cannula.
  • [0029]
    The plugs expand upon exiting the dilator, and may further expand as they rehydrate in the disc space.
  • [0030]
    As to the benefits of the inventive materials and methods, augmentation of the intervertebral disc may restore or improve the natural condition and/or performance of the disc. In addition, augmentation may retard or reverse the progressive degeneration of a dehydrated disc.
  • [0031]
    Reference will now be made to specific examples using the processes described above. It is to be understood that the examples are provided to more completely describe preferred embodiments, and that no limitation to the scope of the invention is intended thereby.
  • EXAMPLE 1A Hydrated Particulate Fascia Lata
  • [0032]
    A suspension of particulate or fibrous (autologous or allogenic) fascia lata is prepared in a biocompatible medium such as saline or ethylene glycol. The particle size ranges from 0.1 mm to 5 mm, with most particles being between 0.25 and 2 mm.
  • [0033]
    The suspension is injected directly into the nuclear disc space through an intact annulus using a hypodermic needle, and is contained within the disc space following injection. The medium subsequently diffuses out of the disc space and leaves the fascia lata material behind.
  • [0034]
    Inspection of the disc reveals that an appropriate level of augmentation may be obtained with a single injection of material. Alternatively, several smaller doses/injections may be used to achieve comparable results.
  • EXAMPLE 1B Hydrated Particulate Fascia Lata with Crosslinking Agent
  • [0035]
    A suspension of particulate or fibrous (autologous or allogenic) fascia lata is prepared in a biocompatible medium such as saline or ethylene glycol. The particle size ranges from 0.1 mm to 5 mm, with most particles being between 0.25 mm and 2 mm. A glutaraldehyde crosslinking agent is added to promote collagen crosslinking.
  • [0036]
    The suspension is injected directly into the nuclear disc space through an intact annulus using a hypodermic needle, and is contained within the disc space following injection. The medium subsequently diffuses out of the disc space and leaves the fascia lata material behind.
  • [0037]
    Inspection of the disc reveals that an appropriate level of augmentation may be obtained through either a single injection of material, or by multiple injections.
  • EXAMPLE 1C Dehydrated Particulate Fascia Lata
  • [0038]
    Dehydrated fascia lata material is provided in particulate form. Particle sizes range between 0.05 mm and 3 mm, with most particles being between 0.10 mm and 1 mm. The dehydrated material is loaded in a specially designed syringe for delivery of solid materials.
  • [0039]
    The material is extruded into the nuclear disc space of the treated disc through a small dilated annular opening. The material remains inside the disc space after the needle is removed. It subsequently absorbs moisture or body fluids and swells up in vivo.
  • [0040]
    Inspection of the disc reveals that an appropriate level of augmentation may be obtained through either a single injection of material, or by multiple injections.
  • EXAMPLE 2A Hydrated Particulate Disc Annulus Material
  • [0041]
    A suspension of particulate or fibrous allogenic annulus fibrosis is prepared in a biocompatible medium such as saline or ethylene glycol. The particle size ranges from 0.1 mm to 5 mm, with most particles being between 0.25 and 2 mm.
  • [0042]
    The suspension is injected directly into the nuclear disc space through an intact annulus using a hypodermic needle. The suspension is contained within the disc space following injection. The medium subsequently diffuses out of the disc space and leaves the annulus fibrosis material behind.
  • [0043]
    Inspection of the disc reveals that an appropriate level of augmentation may be obtained through either a single injection of material, or by multiple injections.
  • EXAMPLE 2B Hydrated Particulate Disc Annulus Material with Crosslinking Agent
  • [0044]
    A suspension of particulate or fibrous allogenic annulus fibrosis is prepared in a biocompatible medium such as saline or ethylene glycol. The particle size ranges from 0.1 mm to 5 mm, with most particles being between 0.25 and 2 mm. A glutaraldehyde crosslinking agent is added to promote collagen crosslinking.
  • [0045]
    The suspension is injected directly into the nuclear disc space through an intact annulus using a hypodermic needle. The suspension is contained within the disc space following injection. The medium subsequently diffuses out of the disc space and leaves the annulus fibrosis material behind.
  • [0046]
    Inspection of the disc reveals that an appropriate level of augmentation may be obtained through either a single injection of material, or by multiple injections.
  • EXAMPLES 3A-3C Dehydrated Annulus Fibrosis
  • [0047]
    Dehydrated annulus fibrosis is provided in granule, particulate and powder form, for example 3A-3C respectively. Particle sizes range between 0.05 mm and 3 mm, with most particles being between 0.10 mm and 1 mm. The dehydrated material is loaded in a specially designed syringe for delivery of solid materials.
  • [0048]
    The material is extruded into the nuclear disc space of the treated disc through a small dilated annular opening. The material remains inside the disc space after the needle is removed. It subsequently absorbs moisture or body fluids and swells up in vivo.
  • [0049]
    Inspection of the disc reveals that an appropriate level of augmentation may be obtained through either a single injection of material, or by multiple injections.
  • EXAMPLES 4A-4B Demineralized Bone Matrix (DBM) Gel
  • [0050]
    Demineralized bone matrix (DBM) gel is provided with and without glutaraldehyde as a cross-linker additive (examples 4A and 4B, respectively). In both cases the material is warmed up to an appropriate temperature for melting or thinning out the gel, and is injected directly into the nuclear disc space through an intact annulus using a hypodermic needle. The DBM gel becomes solidified in the disc space after injection.
  • [0051]
    Inspection of the disc reveals that an appropriate level of augmentation may be obtained through either a single injection of material, or by multiple injections.
  • EXAMPLES 4C Dehydrated Demineralized Bone Matrix (DBM)
  • [0052]
    Dehydrated DBM is provided in granule, particulate and powder form. Particle sizes range between 0.05 mm and 3 mm, with most particles being between 0.10 mm and 1 mm. The dehydrated material is loaded in a specially designed syringe for delivery of solid materials.
  • [0053]
    The material is extruded into the nuclear disc space of the treated disc through a small dilated annular opening. The material remains inside the disc space after the needle is removed. It subsequently absorbs moisture or body fluids and swells up in vivo.
  • [0054]
    Inspection of the disc reveals that an appropriate level of augmentation may be obtained through either a single injection of material, or by multiple injections.
  • EXAMPLE 5A-5D Mixtures of Annulus Fibrosis and Demineralized Bone Matrix
  • [0055]
    Mixtures of particulate and fibrous allogenic annulus fibrosis and demineralized bone matrix (DBM) gel, with and without additives and/or cross-linkers, are provided. The materials are warmed up to an appropriate temperature for melting or thinning out the gel mixture, and are injected directly into the nuclear disc space through an intact annulus using a hypodermic needle. The gel mixture becomes solidified in the disc space after injection.
  • [0056]
    Inspection of the disc reveals that an appropriate level of augmentation may be obtained through either a single injection of material, or by multiple injections.
  • EXAMPLE 6
  • [0057]
    Elongated cylindrical plugs (0.5 mm to 5 mm in diameter, preferably 1 mm to 2 mm) of solid, porous, or fibrous collagen are provided in a dehydrated state. The plugs are compressed in the radial direction and are inserted into delivery cannula for delivery into disc space.
  • [0058]
    A guide wire or needle is used to penetrate the disc space through an intact annulus. A dilator is subsequently inserted into the disc space over the guide wire/needle, and the guide wire/needle is removed. The delivery cannula containing a collagen plug is attached to the dilator prior to extrusion of the plug into the disc space. As the plugs absorb moisture after entering the disc space, they become more compliant, flexible and expanded.
  • [0059]
    The level of disc augmentation achieved depends on the number of plugs inserted, and/or on the total plug volume deposited in the disc space.
  • EXAMPLE 7
  • [0060]
    Cylindrical plugs or rolls (2 mm-20 mm in diameter, preferably 10-15 mm) of solid, porous, or fibrous collagen are provided in a dehydrated state. The dehydrated plugs are typically more rigid than those in hydrated state, and thus, can be easily inserted into the disc space through an annular opening created by trauma or surgical incision.
  • [0061]
    Nucleotomy is necessary before the plug can be inserted. As the plugs absorb moisture after entering the disc space, they become more compliant, flexible and expanded.
  • [0062]
    The level of disc augmentation/replacement achieved depends on the size and number of plugs inserted into the disc space.
  • EXAMPLE 8
  • [0063]
    Particulate fascia used for cosmetic procedure (FASCIAN®) was modified to include a radiocontrast media. A small quantity of barium sulfate powder was blended with 80 mg of >0.5 mm Gastrocemius Fascia for visualization under fluoroscopic imaging. About 1-1.5 cc of water was added to the blend in the syringe for hydration.
  • [0064]
    After hydration for 5-10 minutes, the material (Fascian/Barium Sulfate/Water or F.B.W.) was injected into the nuclear disc space of a harvested porcine intervertebral disc. X-ray images of the disc were obtained before and after injection.
  • [0065]
    A small increase in disc height was noticed after injection. Also, manual compression indicated that the disc was stiffer after injection. The injected disc was also tested under compression up to 5000N. There was no gross leakage observed during the compression test. Only a slight oozing of a small amount of injected material was observed at the injection site, but it stopped quickly.
  • [0066]
    The disc was cut in the horizontal plane to confirm the location of the injected material. F.B.W. was found contained within the disc annulus and mixed in with nucleus pulposus.
  • EXAMPLE 9
  • [0067]
    Particulate fascia used for cosmetic procedures (FASCIAN®) was modified before experimentation to include a radiocontrast material. A small quantity of radiocontrast dye or barium sulfate powder was blended with about 200 mg of 0.25-1.0 mm Gastrocemius Fascia for visualization under fluoroscopic imaging. About 1.5-3 cc of saline was added to the blend in the syringe for hydration.
  • [0068]
    After hydration for about 30 minutes, the material (Fascian/Dye or Barium Sulfate/Water) was injected into the nuclear disc space of cadaveric intervertebral discs (L2-3 and L3-4). X-ray images of the discs were obtained before and after injection. A small increase in disc height was noticed radiographically after injection. There was no gross leakage observed at the injection site. In the case of L3-4 injection, the needle tip was maintained approximately at the center of the disc, which resulted in material deposition mainly within the nucleus pulposus.
  • EXAMPLE 10
  • [0069]
    Particulate fascia (FASCIAN®) having particle sizes of 0.25 mm and 0.5 mm was purchased from Fascia BioSystems. Collagen solutions were prepared, with each solution consisting of approximately 80 mg of particulate fascia, 0.75 ml of saline, and 0.25 ml HYPAQUE® radiocontrast solution.
  • [0070]
    Thoracic and lumbar discs in two pigs were subjected to stabbing injury. The injured discs were then injected with 1-2 ml of collagen solution at 4 weeks after injury. The injections were performed using a 3 ml syringe, a 20 gauge hypodermic needle and a graft placement device. Confirming X-ray was taken using C-arm fluoroscopy.
  • [0071]
    The injured discs appeared to have somewhat reduced heights at four weeks after injury. Of approximately 12 injected discs, there was only one leakage observed. The amount of leakage was visually estimated to be less than 20% of the total volume injected. The low incidence of leakage indicates that the annulus is capable of self-sealing when a small gauge needle is used for injection.
  • [0072]
    The disc height increased upon collagen injection depending on the injected volume. In particular, an approximately 46% increase in disc height was achieved with 2 ml injection. In some cases the disc height gain was reduced after injection as radio-contrast dye and water molecules diffused out of the disc under intra-discal pressure.
  • [0073]
    While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only the preferred embodiment has been shown and described and that all changes and modifications that come within the spirit of the invention are desired to be protected.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3551560 *Oct 2, 1967Dec 29, 1970Heinrich F ThieleProcess of reconstructing tendons,cartilage,nerve sheaths,and products
US3855638 *May 16, 1973Dec 24, 1974Ontario Research FoundationSurgical prosthetic device with porous metal coating
US3875595 *Apr 15, 1974Apr 8, 1975Froning Edward CIntervertebral disc prosthesis and instruments for locating same
US4060081 *Jul 15, 1975Nov 29, 1977Massachusetts Institute Of TechnologyMultilayer membrane useful as synthetic skin
US4085466 *Aug 4, 1977Apr 25, 1978National Research Development CorporationProsthetic joint device
US4280954 *Apr 16, 1979Jul 28, 1981Massachusetts Institute Of TechnologyCrosslinked collagen-mucopolysaccharide composite materials
US4344193 *Nov 28, 1980Aug 17, 1982Kenny Charles HMeniscus prosthesis
US4349921 *Jun 16, 1980Sep 21, 1982Kuntz J DavidIntervertebral disc prosthesis
US4350629 *Jul 29, 1981Sep 21, 1982Massachusetts Institute Of TechnologyProcedures for preparing composite materials from collagen and glycosaminoglycan
US4378224 *Sep 19, 1980Mar 29, 1983Nimni Marcel ECoating for bioprosthetic device and method of making same
US4400833 *Jun 10, 1981Aug 30, 1983Kurland Kenneth ZMeans and method of implanting bioprosthetics
US4418691 *Oct 26, 1981Dec 6, 1983Massachusetts Institute Of TechnologyMethod of promoting the regeneration of tissue at a wound
US4448718 *Sep 13, 1983May 15, 1984Massachusetts Institute Of TechnologyMethod for the preparation of collagen-glycosaminoglycan composite materials
US4458678 *Oct 26, 1981Jul 10, 1984Massachusetts Institute Of TechnologyCell-seeding procedures involving fibrous lattices
US4505266 *Apr 17, 1984Mar 19, 1985Massachusetts Institute Of TechnologyMethod of using a fibrous lattice
US4544516 *Jun 30, 1983Oct 1, 1985Battelle Development CorporationCollagen orientation
US4578079 *Nov 22, 1983Mar 25, 1986La Jolla Cancer Research FoundationTetrapeptide
US4589881 *Jul 28, 1983May 20, 1986La Jolla Cancer Research FoundationPolypeptide
US4614794 *Sep 24, 1984Sep 30, 1986Johnson & JohnsonProtein/polysaccharide complexes
US4627853 *May 29, 1985Dec 9, 1986American Hospital Supply CorporationMethod of producing prostheses for replacement of articular cartilage and prostheses so produced
US4642120 *Mar 21, 1984Feb 10, 1987Ramot University Authority For Applied Research And Industrial Development Ltd.Repair of cartilage and bones
US4661111 *May 17, 1985Apr 28, 1987La Jolla Cancer Research FoundationPolypeptide
US4772287 *Aug 20, 1987Sep 20, 1988Cedar Surgical, Inc.Prosthetic disc and method of implanting
US4787900 *Jan 12, 1987Nov 29, 1988Massachusetts Institute Of TechnologyProcess for forming multilayer bioreplaceable blood vessel prosthesis
US4801299 *Feb 22, 1984Jan 31, 1989University Patents, Inc.Body implants of extracellular matrix and means and methods of making and using such implants
US4837285 *Sep 8, 1987Jun 6, 1989MedimatrixCollagen matrix beads for soft tissue repair
US4879135 *Jul 18, 1988Nov 7, 1989University Of Medicine And Dentistry Of New JerseyDrug bonded prosthesis and process for producing same
US4880492 *Sep 15, 1987Nov 14, 1989Merck Patent Gesellschaft Mit Beschrankter HaftungOrganometallic compounds
US4907260 *Jun 5, 1989Mar 6, 1990Ambassador CollegeTelephone line communications control system
US4946792 *Aug 18, 1989Aug 7, 1990Osteotech, Inc.Process for debriding bone
US4976733 *Jan 27, 1989Dec 11, 1990Biomedical Design, Inc.Prevention of prosthesis calcification
US5007934 *Mar 2, 1989Apr 16, 1991Regen CorporationProsthetic meniscus
US5067962 *Sep 28, 1990Nov 26, 1991Baxter International Inc.Bioprosthetic ligament
US5108438 *May 7, 1990Apr 28, 1992Regen CorporationProsthetic intervertebral disc
US5192326 *Sep 9, 1991Mar 9, 1993Pfizer Hospital Products Group, Inc.Hydrogel bead intervertebral disc nucleus
US5229497 *Oct 3, 1990Jul 20, 1993Teepak, Inc.Process for recovering collagen
US5258043 *Dec 26, 1991Nov 2, 1993Regen CorporationMethod for making a prosthetic intervertebral disc
US5507810 *Dec 21, 1992Apr 16, 1996Osteotech, Inc.Processing of fibrous connective tissue
US5607476 *Feb 9, 1996Mar 4, 1997Osteotech, Inc.Processing of fibrous connective tissue
US5713959 *Dec 20, 1994Feb 3, 1998Scott P. BartlettSoft tissue implants
US5733337 *Apr 7, 1995Mar 31, 1998Organogenesis, Inc.Tissue repair fabric
US5922028 *Oct 16, 1997Jul 13, 1999Depuy Orthopaedics, Inc.Multi-layered SIS tissue graft construct for replacement of cartilaginous elements in situ
US5964807 *Aug 8, 1996Oct 12, 1999Trustees Of The University Of PennsylvaniaCompositions and methods for intervertebral disc reformation
US5980504 *Jun 24, 1997Nov 9, 1999Oratec Interventions, Inc.Method for manipulating tissue of an intervertebral disc
US6007570 *Jun 24, 1997Dec 28, 1999Oratec Interventions, Inc.Apparatus with functional element for performing function upon intervertebral discs
US6022376 *Mar 16, 1998Feb 8, 2000Raymedica, Inc.Percutaneous prosthetic spinal disc nucleus and method of manufacture
US6025538 *Nov 20, 1998Feb 15, 2000Musculoskeletal Transplant FoundationCompound bone structure fabricated from allograft tissue
US6073051 *Jun 24, 1997Jun 6, 2000Oratec Interventions, Inc.Apparatus for treating intervertebal discs with electromagnetic energy
US6077989 *May 15, 1997Jun 20, 2000Kandel; RitaResorbable implant biomaterial made of condensed calcium phosphate particles
US6080194 *Feb 10, 1995Jun 27, 2000The Hospital For Joint Disease Orthopaedic InstituteMulti-stage collagen-based template or implant for use in the repair of cartilage lesions
US6095149 *Jun 24, 1997Aug 1, 2000Oratec Interventions, Inc.Method for treating intervertebral disc degeneration
US6099514 *Sep 29, 1998Aug 8, 2000Oratec Interventions, Inc.Method and apparatus for delivering or removing material from the interior of an intervertebral disc
US6122549 *Jun 24, 1997Sep 19, 2000Oratec Interventions, Inc.Apparatus for treating intervertebral discs with resistive energy
US6123731 *Feb 6, 1998Sep 26, 2000Osteotech, Inc.Osteoimplant and method for its manufacture
US6126682 *Sep 15, 1998Oct 3, 2000Oratec Interventions, Inc.Method for treating annular fissures in intervertebral discs
US6140452 *Nov 18, 1998Oct 31, 2000Advanced Bio Surfaces, Inc.Biomaterial for in situ tissue repair
US6146422 *Jan 25, 1999Nov 14, 2000Lawson; Kevin JonProsthetic nucleus replacement for surgical reconstruction of intervertebral discs and treatment method
US6176880 *Apr 4, 1997Jan 23, 2001Depuy Orthopaedics, Inc.Tissue graft construct for replacement of cartilaginous structures
US6224630 *May 29, 1998May 1, 2001Advanced Bio Surfaces, Inc.Implantable tissue repair device
US6240926 *May 19, 1999Jun 5, 2001The Trustees Of The University Of PennsylvaniaCompositions and methods for intervertebral disc reformation
US6261311 *Jul 30, 1999Jul 17, 2001Oratec Interventions, Inc.Method and apparatus for treating intervertebral discs
US6264695 *Sep 30, 1999Jul 24, 2001Replication Medical, Inc.Spinal nucleus implant
US6290715 *Jan 25, 1999Sep 18, 2001Oratec Interventions, Inc.Method for delivering energy adjacent the inner wall of an intervertebral disc
US6306169 *Nov 9, 1998Oct 23, 2001Abonetics Ltd.Tissue implant
US6306177 *Dec 18, 1997Oct 23, 2001Advanced Bio Surfaces, Inc.Biomaterial system for in situ tissue repair
US6322786 *Feb 13, 1997Nov 27, 2001Kansas University Medical Center Research Institute, Inc.Method of producing bone-inducing agent
US6340369 *Aug 14, 2000Jan 22, 2002Bret A. FerreeTreating degenerative disc disease with harvested disc cells and analogues of the extracellular matrix
US6344058 *Aug 14, 2000Feb 5, 2002Bret A. FerreeTreating degenerative disc disease through transplantation of allograft disc and vertebral endplates
US6352557 *Aug 14, 2000Mar 5, 2002Bret A. FerreeTreating degenerative disc disease through transplantion of extracellular nucleus pulposus matrix and autograft nucleus pulposus cells
US6352558 *Dec 29, 1999Mar 5, 2002Ed. Geistlich Soehne Ag Fuer Chemische IndustrieMethod for promoting regeneration of surface cartilage in a damage joint
US6402784 *Jul 10, 1998Jun 11, 2002Aberdeen Orthopaedic Developments LimitedIntervertebral disc nucleus prosthesis
US6425919 *Jun 30, 2000Jul 30, 2002Intrinsic Orthopedics, Inc.Devices and methods of vertebral disc augmentation
US6428576 *Apr 14, 2000Aug 6, 2002Endospine, Ltd.System for repairing inter-vertebral discs
US6623963 *Dec 20, 1999Sep 23, 2003Verigen AgCellular matrix
US6641587 *Jul 13, 2001Nov 4, 2003Kyphon Inc.Systems and methods for treating vertebral bodies
US20020029083 *Mar 22, 2001Mar 7, 2002Zucherman James F.Implantable prosthetic or tissue expanding device
US20020038150 *Apr 18, 2001Mar 28, 2002Urry Dan W.Injectable implants for tissue augmentation and restoration
US20020116069 *Apr 23, 2001Aug 22, 2002Urry Dan W.Injectable implants for tissue augmentation and restoration
US20020120347 *Aug 13, 2001Aug 29, 2002Boyer Ii Michael L.Demineralized bone implants
US20030130664 *Jan 17, 2003Jul 10, 2003Kyphon Inc.Systems and methods for treating vertebral bodies
US20030158607 *Feb 28, 2003Aug 21, 2003Carr Robert M.Tissue repair fabric
US20040010251 *Dec 10, 2002Jan 15, 2004Shahar PitaruMethods, devices, and preparations for intervertebral disc treatment
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7294617 *Sep 9, 2004Nov 13, 2007Depuy Acromed, Inc.Method for nonsurgical treatment of the intervertebral disc and kit therefor
US7309359 *Aug 21, 2003Dec 18, 2007Warsaw Orthopedic, Inc.Allogenic/xenogenic implants and methods for augmenting or repairing intervertebral discs
US7435260 *Jun 25, 2004Oct 14, 2008Ferree Bret AUse of morphogenetic proteins to treat human disc disease
US7452351 *Apr 16, 2004Nov 18, 2008Kyphon SarlSpinal diagnostic methods and apparatus
US7670379Mar 2, 2010Anulex Technologies, Inc.Spinal disc annulus reconstruction method
US7670380Mar 2, 2010Anulex Technologies, Inc.Intervertebral disc annulus stent
US7713303Apr 28, 2005May 11, 2010Warsaw Orthopedic, Inc.Collagen-based materials and methods for augmenting intervertebral discs
US7731981Jan 23, 2007Jun 8, 2010Warsaw Orthopedic, Inc.Collagen-based materials and methods for treating synovial joints
US7744651Jun 29, 2010Warsaw Orthopedic, IncCompositions and methods for treating intervertebral discs with collagen-based materials
US7749273Jul 6, 2010Anulex Technologies, Inc.Method and apparatus for the treatment of the intervertebral disc annulus
US7753941Jul 13, 2010Anulex Technologies, Inc.Devices and methods for annular repair of intervertebral discs
US7771478Apr 2, 2004Aug 10, 2010Theken Spine, LlcArtificial disc prosthesis
US7824390Dec 26, 2006Nov 2, 2010Kyphon SÀRLSpinal diagnostic methods and apparatus
US7828850Feb 10, 2006Nov 9, 2010Anulex Technologies, Inc.Methods and devices for spinal disc annulus reconstruction and repair
US7846208Aug 30, 2006Dec 7, 2010Anulex Technologies, Inc.Spinal disc annulus reconstruction method and deformable spinal disc annulus stent
US7879103 *Apr 17, 2006Feb 1, 2011Musculoskeletal Transplant FoundationVertebral disc repair
US7905874Dec 26, 2006Mar 15, 2011Kyphon SarlSpinal diagnostic methods and apparatus
US7905923Mar 15, 2011Anulex Technologies, Inc.Devices and methods for annular repair of intervertebral discs
US7909879Nov 9, 2006Mar 22, 2011Anulex Technologies, Inc.Intervertebral disc annulus stent
US7922768Nov 14, 2006Apr 12, 2011Anulex Technologies, Inc.Spinal disc annulus reconstruction method and deformable spinal disc annulus stent
US7935147Sep 26, 2005May 3, 2011Anulex Technologies, Inc.Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus
US7951201Jan 12, 2007May 31, 2011Anulex Technologies, Inc.Method and apparatus for the treatment of the intervertebral disc annulus
US7955312Jun 7, 2011Kyphon SarlSpinal diagnostic methods and apparatus
US7959683Jun 14, 2011Musculoskeletal Transplant FoundationPacked demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation
US7963992Jun 21, 2011Anulex Technologies, Inc.Method and apparatus for the treatment of the intervertebral disc annulus
US7985257Nov 6, 2006Jul 26, 2011Anulex Technologies, Inc.Methods and devices for spinal disc annulus reconstruction and repair
US7993405Dec 8, 2006Aug 9, 2011Anulex Technologies, Inc.Spinal disc annulus repair system and methods
US8016859Sep 13, 2011Medtronic, Inc.Dynamic treatment system and method of use
US8034112Oct 11, 2011Anulex Technologies, Inc.Spinal disc annulus reconstruction method and spinal disc annulus stent
US8048160Nov 1, 2011Anulex Technologies, Inc.Intervertebral disc annulus stent
US8057458Oct 30, 2006Nov 15, 2011Warsaw Orthopedic, Inc.Method for treating facet pain
US8088165Mar 23, 2006Jan 3, 2012Anulex Technologies, Inc.Spinal disc annulus reconstruction method and deformable spinal disc annulus stent
US8118779 *Jun 30, 2006Feb 21, 2012Warsaw Orthopedic, Inc.Collagen delivery device
US8127770Aug 30, 2005Mar 6, 2012Spineovations, Inc.Method of using an implant for treament of ligaments and tendons
US8128698Oct 14, 2008Mar 6, 2012Anulex Technologies, Inc.Method and apparatus for the treatment of the intervertebral disc annulus
US8157786Dec 26, 2006Apr 17, 2012Kyphon SarlSpinal diagnostic methods and apparatus
US8163018Feb 14, 2006Apr 24, 2012Warsaw Orthopedic, Inc.Treatment of the vertebral column
US8163022Apr 24, 2012Anulex Technologies, Inc.Method and apparatus for the treatment of the intervertebral disc annulus
US8197545Jun 12, 2012Depuy Spine, Inc.Nucleus augmentation delivery device and technique
US8357199Apr 3, 2012Jan 22, 2013Depuy Spine, Inc.Nucleus augmentation delivery device and technique
US8398638 *Aug 30, 2005Mar 19, 2013Spineovations, Inc.Method of treating spinal internal disk derangement
US8399619Jun 30, 2006Mar 19, 2013Warsaw Orthopedic, Inc.Injectable collagen material
US8454697Apr 5, 2012Jun 4, 2013Anulex Technologies, Inc.Method and apparatus for the treatment of tissue
US8460319Jun 11, 2013Anulex Technologies, Inc.Intervertebral disc annulus repair system and method
US8469961Mar 4, 2009Jun 25, 2013Neville AlleyneMethods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8506633Dec 27, 2005Aug 13, 2013Warsaw Orthopedic, Inc.Rehydration and restoration of intervertebral discs with polyelectrolytes
US8556977Nov 12, 2010Oct 15, 2013Anulex Technologies, Inc.Tissue anchoring system and method
US8562613 *Apr 5, 2010Oct 22, 2013Spineology Inc.Method kit for treating bony defects
US8632590Sep 26, 2006Jan 21, 2014Anulex Technologies, Inc.Apparatus and methods for the treatment of the intervertebral disc
US8652153Aug 10, 2010Feb 18, 2014Anulex Technologies, Inc.Intervertebral disc annulus repair system and bone anchor delivery tool
US8657859Dec 15, 2010Feb 25, 2014Advanced Veterinary SolutionsImplant for promoting stability of the canine stifle joint
US8697139Sep 21, 2004Apr 15, 2014Frank M. PhillipsMethod of intervertebral disc treatment using articular chondrocyte cells
US8801790Dec 27, 2005Aug 12, 2014Warsaw Orthopedic, Inc.Intervertebral disc augmentation and rehydration with superabsorbent polymers
US8864801 *Apr 30, 2007Oct 21, 2014Warsaw Orthopedic, Inc.Method of deformity correction in a spine using injectable materials
US8951255Mar 8, 2013Feb 10, 2015Spineovations, Inc.Method of treating spinal internal disk derangement
US8974502 *Oct 30, 2008Mar 10, 2015Warsaw Orthopedic, Inc.Methods, systems, and devices for treating intervertebral discs including intradiscal fluid evacuation
US9011543Oct 31, 2007Apr 21, 2015Warsaw Orthopedic, Inc.Methods for augmenting or repairing intervertebral discs with allogenic/xenogenic implants
US9095442Jan 23, 2012Aug 4, 2015Krt Investors, Inc.Method and apparatus for the treatment of the intervertebral disc annulus
US9114025Jun 29, 2011Aug 25, 2015Krt Investors, Inc.Methods and devices for spinal disc annulus reconstruction and repair
US9119732Mar 15, 2013Sep 1, 2015Orthocision, Inc.Method and implant system for sacroiliac joint fixation and fusion
US9132207Oct 27, 2009Sep 15, 2015Spine Wave, Inc.Radiopaque injectable nucleus hydrogel compositions
US9162041Jan 14, 2013Oct 20, 2015DePuy Synthes Products, Inc.Nucleus augmentation delivery device and technique
US9192372Jun 3, 2013Nov 24, 2015Krt Investors, Inc.Method for the treatment of tissue
US9238090Dec 24, 2014Jan 19, 2016Fettech, LlcTissue-based compositions
US9351769 *Feb 6, 2015May 31, 2016Spineovations, Inc.Method of treating spinal internal disk derangement
US20030220648 *Apr 22, 2003Nov 27, 2003Kyphon Inc.Methods and devices for treating fractured and/or diseased bone
US20030220693 *Mar 24, 2003Nov 27, 2003Cauthen Joseph C.Intervertebral disc annulus repair devices and methods
US20040010251 *Dec 10, 2002Jan 15, 2004Shahar PitaruMethods, devices, and preparations for intervertebral disc treatment
US20040186471 *Dec 7, 2002Sep 23, 2004Sdgi Holdings, Inc.Method and apparatus for intervertebral disc expansion
US20040230310 *Jun 25, 2004Nov 18, 2004Ferree Bret A.Use of morphogenic proteins to treat human disc disease
US20050002909 *Mar 29, 2004Jan 6, 2005Centerpulse Biologics IncMethods and compositions for treating intervertebral disc degeneration
US20050038518 *Sep 9, 2004Feb 17, 2005Depuy Spine, Inc.Method for nonsurgical treatment of the intervertebral disc and kit therefor
US20050043801 *Aug 21, 2003Feb 24, 2005Trieu Hai H.Allogenic/xenogenic implants and methods for augmenting or repairing intervertebral discs
US20050071012 *Sep 30, 2003Mar 31, 2005Hassan SerhanMethods and devices to replace spinal disc nucleus pulposus
US20050119754 *Jan 6, 2005Jun 2, 2005Trieu Hai H.Compositions and methods for treating intervertebral discs with collagen-based materials
US20050131417 *Aug 23, 2004Jun 16, 2005Ahern James W.Kit for treating bony defects
US20050209699 *Mar 29, 2005Sep 22, 2005Slivka Michael AMethod for nonsurgical treatment of the nucleus pulposus of the intervertebral disc using genipin or proanthrocyanidin, and kit therefor
US20050234425 *Apr 16, 2004Oct 20, 2005Innospine, Inc.Spinal diagnostic methods and apparatus
US20050277921 *May 28, 2004Dec 15, 2005Sdgi Holdings, Inc.Prosthetic joint and nucleus supplement
US20060074423 *Aug 30, 2005Apr 6, 2006Neville AlleyneMethod of using an implant for treament of ligaments and tendons
US20060074424 *Aug 30, 2005Apr 6, 2006Neville AlleyneMethod of treating spinal internal disk derangement
US20060136061 *Apr 2, 2004Jun 22, 2006Theken Disc, LlcArtificial disc prosthesis
US20060235534 *Apr 17, 2006Oct 19, 2006Gertzman Arthur AVertebral disc repair
US20060287731 *Aug 30, 2006Dec 21, 2006Cauthen Joseph C IiiSpinal disc annulus reconstruction method and deformable spinal disc annulus stent
US20070001981 *Jun 27, 2006Jan 4, 2007Nec Electronics CorporationDriver unit including common level shifter circuit for display panel and nonvolatile memory
US20070003525 *Feb 2, 2004Jan 4, 2007Moehlenbruck Jeffrey WHydrogel compositions comprising nucleus pulposus tissue
US20070061012 *Sep 15, 2006Mar 15, 2007Cauthen Joseph C IiiIntervertebral disc annulus stent
US20070100349 *Oct 27, 2005May 3, 2007O'neil MichaelNucleus augmentation delivery device and technique
US20070150060 *Dec 27, 2005Jun 28, 2007Sdgi Holdings, IncRehydration and restoration of intervertebral discs with polyelectrolytes
US20070150061 *Dec 27, 2005Jun 28, 2007Sdgi Holdings, Inc.Intervertebral disc augmentation and rehydration with superabsorbent polymers
US20070191861 *Jan 30, 2006Aug 16, 2007Sdgi Holdings, Inc.Instruments and methods for implanting nucleus replacement material in an intervertebral disc nucleus space
US20070213717 *Feb 14, 2006Sep 13, 2007Sdgi Holdings, Inc.Biological fusion in the vertebral column
US20070213718 *Feb 14, 2006Sep 13, 2007Sdgi Holdings, Inc.Treatment of the vertebral column
US20070213822 *Feb 14, 2006Sep 13, 2007Sdgi Holdings, Inc.Treatment of the vertebral column
US20070213824 *Feb 14, 2006Sep 13, 2007Sdgi Holdings, Inc.Treatment of the vertebral column
US20070227547 *Feb 14, 2006Oct 4, 2007Sdgi Holdings, Inc.Treatment of the vertebral column
US20070293428 *Jun 19, 2006Dec 20, 2007Zanella John MMethods of treating joint pain in a subject by using an anti-angiogenic agent
US20080004214 *Jun 30, 2006Jan 3, 2008Warsaw Orthopedic, IncInjectable collagen material
US20080004431 *Jun 30, 2006Jan 3, 2008Warsaw Orthopedic IncMethod of manufacturing an injectable collagen material
US20080004570 *Jun 30, 2006Jan 3, 2008Warsaw Orthopedic, Inc.Collagen delivery device
US20080004703 *Jun 30, 2006Jan 3, 2008Warsaw Orthopedic, Inc.Method of treating a patient using a collagen material
US20080021435 *Dec 26, 2006Jan 24, 2008Kyphon, Inc.Spinal diagnostic methods and apparatus
US20080027546 *Jul 23, 2007Jan 31, 2008Semler Eric JPacked demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation
US20080058952 *Oct 31, 2007Mar 6, 2008Trieu Hai HAllogenic/xenogenic implants and methods for augmenting or repairing intervertebral discs
US20080058954 *Aug 22, 2006Mar 6, 2008Hai TrieuMethods of treating spinal injuries using injectable flowable compositions comprising organic materials
US20080077117 *Dec 26, 2006Mar 27, 2008Kyphon, Inc.Spinal diagnostic methods and apparatus
US20080077172 *Dec 26, 2006Mar 27, 2008Kyphon, Inc.Spinal diagnostic methods and apparatus
US20080096976 *Oct 19, 2007Apr 24, 2008Neville AlleyneMethod of treating spinal internal disk derangement
US20080177218 *Oct 30, 2006Jul 24, 2008Mckay William FMethod for treating facet pain
US20080269717 *Apr 30, 2007Oct 30, 2008Crandall Dennis GMethod of deformity correction in a spine using injectable materials
US20080299172 *Jun 3, 2008Dec 4, 2008Stuart YoungTissue repair implant
US20090036989 *Oct 8, 2008Feb 5, 2009Anulex Technologies, Inc.Method and Apparatus for the Treatment of the Intervertebral Disc Annulus
US20100004699 *Mar 4, 2009Jan 7, 2010Neville AlleyneMethods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US20100004700 *Mar 5, 2009Jan 7, 2010Neville AlleyneMethod of treating tissue with a suspenson of tricalcium hydroxyapatite microspheres
US20100010549 *Jan 14, 2010Neville Alleynedevice and method of minimally invasive extracapsular ligamentous augmentation for canine stifle ligament injuries
US20100040604 *Oct 13, 2009Feb 18, 2010Salfeld Jochen GHUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
US20100114069 *Oct 30, 2008May 6, 2010Warsaw Orthopedic, Inc.Methods, Systems, and Devices for Treating Intervertebral Discs Including Intradiscal Fluid Evacuation
US20100268282 *Oct 21, 2010Warsaw Orthopedic, Inc.Anterior spinal plate with preformed drug-eluting device affixed thereto
US20100286702 *Apr 5, 2010Nov 11, 2010Ahern James WMethod kit for treating bony defects
US20110230919 *Sep 22, 2011Neville AlleyneImplant for promoting stability of the canine stifle joint
US20130282121 *Mar 22, 2013Oct 24, 2013Ann PrewettSpinal facet augmentation implant and method
US20150238234 *Feb 6, 2015Aug 27, 2015Spineovations, Inc.Method of treating spinal internal disk derangement
CN104411273A *Jun 14, 2013Mar 11, 2015香港大学Materials and methods for filling biological cavities and preventing leakage of injected therapeutic agents
EP2206469A2 *Jun 20, 2006Jul 14, 2010Synthes GmbHApparatus for treating bone
WO2005117765A1 *May 24, 2005Dec 15, 2005Sdgi Holdings, Inc.Prosthetic facet joint and nucleus supplement
WO2006026731A1 *Aug 30, 2005Mar 9, 2006Spineovations, Inc.Method of treating spinal internal disk derangement
WO2012061024A1 *Oct 20, 2011May 10, 2012Musculoskeletal Transplant FoundationDemineralized cortical bone implants
WO2013185634A1 *Jun 14, 2013Dec 19, 2013The University Of Hong KongMaterials and methods for filling biological cavities and preventing leakage of injected therapeutic agents
Legal Events
DateCodeEventDescription
Sep 15, 2003ASAssignment
Owner name: SDGI HOLDINGS, INC., DELAWARE
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TRIEU, HAI H.;SHERMAN, MICHAEL C.;REEL/FRAME:014490/0412
Effective date: 20030829
Dec 1, 2006ASAssignment
Owner name: WARSAW ORTHOPEDIC, INC., INDIANA
Free format text: MERGER;ASSIGNOR:SDGI HOLDINGS, INC.;REEL/FRAME:018573/0086
Effective date: 20061201
Owner name: WARSAW ORTHOPEDIC, INC.,INDIANA
Free format text: MERGER;ASSIGNOR:SDGI HOLDINGS, INC.;REEL/FRAME:018573/0086
Effective date: 20061201
Oct 7, 2014ASAssignment
Owner name: WARSAW ORTHOPEDIC, INC, INDIANA
Free format text: CORRECTIVE ASSIGNMENT TO CORRECT T0 REMOVE APPLICATION NUMBER PREVIOUSLY RECORDED AT REEL: 018573 FRAME: 0086. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER;ASSIGNOR:SDGI HOLDINGS, INC.;REEL/FRAME:033904/0891
Effective date: 20061201